Matches in SemOpenAlex for { <https://semopenalex.org/work/W2907335912> ?p ?o ?g. }
- W2907335912 endingPage "93" @default.
- W2907335912 startingPage "76" @default.
- W2907335912 abstract "Genomic sequencing provides many opportunities in newborn clinical care, but the challenges of interpreting and reporting newborn genomic sequencing (nGS) results need to be addressed for its broader and effective application. The BabySeq Project is a pilot randomized clinical trial that explores the medical, behavioral, and economic impacts of nGS in well newborns and those admitted to a neonatal intensive care unit (NICU). Here we present childhood-onset and actionable adult-onset disease risk, carrier status, and pharmacogenomics findings from nGS of 159 newborns in the BabySeq Project. nGS revealed a risk of childhood-onset disease in 15/159 (9.4%) newborns; none of the disease risks were anticipated based on the infants’ known clinical or family histories. nGS also revealed actionable adult-onset disease risk in 3/85 (3.5%) newborns whose parents consented to receive this information. Carrier status for recessive diseases and pharmacogenomics variants were reported in 88% and 5% of newborns, respectively. Additional indication-based analyses were performed in 29/32 (91%) NICU newborns and 6/127 (5%) healthy newborns who later had presentations that prompted a diagnostic analysis. No variants that sufficiently explained the reason for the indications were identified; however, suspicious but uncertain results were reported in five newborns. Testing parental samples contributed to the interpretation and reporting of results in 13/159 (8%) newborns. Our results suggest that nGS can effectively detect risk and carrier status for a wide range of disorders that are not detectable by current newborn screening assays or predicted based on the infant’s known clinical or family history, and the interpretation of results can substantially benefit from parental testing. Genomic sequencing provides many opportunities in newborn clinical care, but the challenges of interpreting and reporting newborn genomic sequencing (nGS) results need to be addressed for its broader and effective application. The BabySeq Project is a pilot randomized clinical trial that explores the medical, behavioral, and economic impacts of nGS in well newborns and those admitted to a neonatal intensive care unit (NICU). Here we present childhood-onset and actionable adult-onset disease risk, carrier status, and pharmacogenomics findings from nGS of 159 newborns in the BabySeq Project. nGS revealed a risk of childhood-onset disease in 15/159 (9.4%) newborns; none of the disease risks were anticipated based on the infants’ known clinical or family histories. nGS also revealed actionable adult-onset disease risk in 3/85 (3.5%) newborns whose parents consented to receive this information. Carrier status for recessive diseases and pharmacogenomics variants were reported in 88% and 5% of newborns, respectively. Additional indication-based analyses were performed in 29/32 (91%) NICU newborns and 6/127 (5%) healthy newborns who later had presentations that prompted a diagnostic analysis. No variants that sufficiently explained the reason for the indications were identified; however, suspicious but uncertain results were reported in five newborns. Testing parental samples contributed to the interpretation and reporting of results in 13/159 (8%) newborns. Our results suggest that nGS can effectively detect risk and carrier status for a wide range of disorders that are not detectable by current newborn screening assays or predicted based on the infant’s known clinical or family history, and the interpretation of results can substantially benefit from parental testing." @default.
- W2907335912 created "2019-01-11" @default.
- W2907335912 creator A5002943479 @default.
- W2907335912 creator A5005494787 @default.
- W2907335912 creator A5010862515 @default.
- W2907335912 creator A5014144046 @default.
- W2907335912 creator A5041531862 @default.
- W2907335912 creator A5043141660 @default.
- W2907335912 creator A5052669092 @default.
- W2907335912 creator A5056568766 @default.
- W2907335912 creator A5065618896 @default.
- W2907335912 creator A5067147799 @default.
- W2907335912 creator A5073484637 @default.
- W2907335912 creator A5080516152 @default.
- W2907335912 creator A5084319647 @default.
- W2907335912 creator A5085906183 @default.
- W2907335912 creator A5091462883 @default.
- W2907335912 date "2019-01-01" @default.
- W2907335912 modified "2023-10-17" @default.
- W2907335912 title "Interpretation of Genomic Sequencing Results in Healthy and Ill Newborns: Results from the BabySeq Project" @default.
- W2907335912 cites W1564417183 @default.
- W2907335912 cites W1925825565 @default.
- W2907335912 cites W1967476238 @default.
- W2907335912 cites W1978953141 @default.
- W2907335912 cites W1979114799 @default.
- W2907335912 cites W1986505248 @default.
- W2907335912 cites W1997113840 @default.
- W2907335912 cites W2012449701 @default.
- W2907335912 cites W2015966623 @default.
- W2907335912 cites W2017753640 @default.
- W2907335912 cites W2022017490 @default.
- W2907335912 cites W2048638248 @default.
- W2907335912 cites W2056668451 @default.
- W2907335912 cites W2063091609 @default.
- W2907335912 cites W2072931688 @default.
- W2907335912 cites W2074072691 @default.
- W2907335912 cites W2078319644 @default.
- W2907335912 cites W2089493559 @default.
- W2907335912 cites W2089814842 @default.
- W2907335912 cites W2091831926 @default.
- W2907335912 cites W2093451565 @default.
- W2907335912 cites W2098450085 @default.
- W2907335912 cites W2107071805 @default.
- W2907335912 cites W2117425767 @default.
- W2907335912 cites W2121251640 @default.
- W2907335912 cites W2123984172 @default.
- W2907335912 cites W2124516451 @default.
- W2907335912 cites W2124908019 @default.
- W2907335912 cites W2135024252 @default.
- W2907335912 cites W2137395554 @default.
- W2907335912 cites W2138956466 @default.
- W2907335912 cites W2145922766 @default.
- W2907335912 cites W2150054282 @default.
- W2907335912 cites W2156172320 @default.
- W2907335912 cites W2158830336 @default.
- W2907335912 cites W2161906835 @default.
- W2907335912 cites W2162634302 @default.
- W2907335912 cites W2163556807 @default.
- W2907335912 cites W2167246617 @default.
- W2907335912 cites W2237399873 @default.
- W2907335912 cites W2292085035 @default.
- W2907335912 cites W2293996523 @default.
- W2907335912 cites W2327543792 @default.
- W2907335912 cites W2336359132 @default.
- W2907335912 cites W2526838837 @default.
- W2907335912 cites W2562408240 @default.
- W2907335912 cites W2571528005 @default.
- W2907335912 cites W2575447387 @default.
- W2907335912 cites W2578037138 @default.
- W2907335912 cites W2586377766 @default.
- W2907335912 cites W2594477426 @default.
- W2907335912 cites W2601920136 @default.
- W2907335912 cites W2611940182 @default.
- W2907335912 cites W2616302857 @default.
- W2907335912 cites W2618414694 @default.
- W2907335912 cites W2762508685 @default.
- W2907335912 cites W2770024955 @default.
- W2907335912 cites W2801308007 @default.
- W2907335912 cites W2868826599 @default.
- W2907335912 cites W2886154677 @default.
- W2907335912 cites W2889401411 @default.
- W2907335912 cites W2949506289 @default.
- W2907335912 cites W3004208181 @default.
- W2907335912 cites W3186521396 @default.
- W2907335912 cites W4230235846 @default.
- W2907335912 cites W43806604 @default.
- W2907335912 cites W872640218 @default.
- W2907335912 doi "https://doi.org/10.1016/j.ajhg.2018.11.016" @default.
- W2907335912 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6323417" @default.
- W2907335912 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30609409" @default.
- W2907335912 hasPublicationYear "2019" @default.
- W2907335912 type Work @default.
- W2907335912 sameAs 2907335912 @default.
- W2907335912 citedByCount "147" @default.
- W2907335912 countsByYear W29073359122019 @default.
- W2907335912 countsByYear W29073359122020 @default.
- W2907335912 countsByYear W29073359122021 @default.
- W2907335912 countsByYear W29073359122022 @default.